These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4089643)

  • 1. [Treatment of ischemic heart disease with verapamil].
    Ostapiuk FE; Dobrotvorskaia TE; Khavazha KhA
    Sov Med; 1985; (11):78-81. PubMed ID: 4089643
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of propranolol and verapamil in patients with ischemic heart disease].
    Chizh VD
    Vrach Delo; 1990 Feb; (2):15-8. PubMed ID: 2339541
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of nitroglycerin on left ventricular contraction in ischemic heart disease].
    Ekha IaE; Lukha OA; Leĭssoo AR
    Klin Med (Mosk); 1981 Mar; 59(3):36-40. PubMed ID: 6790816
    [No Abstract]   [Full Text] [Related]  

  • 4. [Combined obzidan and verapamil treatment of ischemic heart disease patients].
    Furkalo NK; Zaĭtseva VI
    Ter Arkh; 1987; 59(9):120-2. PubMed ID: 3424175
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of isoptin on intrahepatic and central hemodynamics in ischemic heart disease].
    Komissarov VA
    Klin Med (Mosk); 1987 Sep; 65(9):64-7. PubMed ID: 3695314
    [No Abstract]   [Full Text] [Related]  

  • 6. [Electrocardiographic and hemodynamic disorders induced by verapamil: experimental study].
    Belardinelli L; Sant'Anna JR; Mattos E; Wagner EM; Lucchese FA
    Arq Bras Cardiol; 1977 Feb; 30 Suppl 1():31-6. PubMed ID: 329806
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hemodynamic and electrocardiographic effects of verapamil in ischemic cardiopathy].
    Aquaro G; Belli R; Ravera A; Rey L; Possavino G; Trucco G; Pavia M; Idone P
    Boll Soc Ital Cardiol; 1981; 26(12):2143-6. PubMed ID: 7185381
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of verapamil on left ventricular contraction in patients with coronary disease].
    Goch JH; Kuklewicz C; Organiszczak K; Tkaczewski W
    Wiad Lek; 1976 Sep; 29(17):1502-4. PubMed ID: 983029
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of verapamil on echocardiographic dimensions of the left ventricle in ischemic cardiopathy: comparison with placebo, propranolol and trinitroglycerin].
    Fonzo R; Cherchi A; Bina P; Mercuro G; Lai C; Cioglia G; Sau F
    Boll Soc Ital Cardiol; 1979; 24(6):623-35. PubMed ID: 121796
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of finoptin on cerebrocardiac correlations in atherosclerotic circulatory encephalopathy in patients with ischemic heart disease].
    Dubenko OE; Ermakovich II
    Vrach Delo; 1988 Mar; (3):39-42. PubMed ID: 3394295
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of different groups of adrenergic beta receptor blockaders on the clinical course of the disease, work capacity and echocardiographic indicators in ischemic heart disease].
    Komarov FI; Ol'binskaia LI; Bragina GI
    Ter Arkh; 1979; 51(8):13-7. PubMed ID: 41333
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of sensit on the course of ischemic heart disease].
    Nesvetov VN; Gorshkov VA; Kuliamin VI; Buskin VD
    Sov Med; 1988; (3):57-61. PubMed ID: 3413552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of visken and cordarone on myocardial function in patients with ischemic heart disease].
    Cherevatov BG; Kucherenko OD; Boiarshin SV
    Sov Med; 1983; (8):65-7. PubMed ID: 6648656
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the indicators of intracardiac hemodynamics in patients with post-infarction cardiosclerosis under the action of verapamil].
    Komissarov VA
    Kardiologiia; 1990 Aug; 30(8):60-3. PubMed ID: 2147729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in cardiovascular function induced by verapamil in healthy subjects and in patients with ischemic heart disease.
    Vincenzi M; Morlino T; Allegri P; Barbieri E; Cappelletti F; De Lio U; Ometto R; Maiolino P
    Clin Cardiol; 1981 Jan; 4(1):15-21. PubMed ID: 7226586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of the optimal dose of finoptin on various components of the circulatory system in heart failure in patients with ischemic heart disease].
    Denisiuk VI; Belokonnaia NS
    Kardiologiia; 1990 Jul; 30(7):72-4. PubMed ID: 2232469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic and coronary effects of intravenous verapamil in coronary insufficiency].
    Zygelman M; Mérillon JP; Guiomard A; Eustigneff T; Zannier D; Gourgon R
    Arch Mal Coeur Vaiss; 1981 Jun; 74(6):685-94. PubMed ID: 6794490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of a single dose of nifedipine on the cardiovascular system of coronary patients].
    Słomińska-Petelenz T; Petelenz T; Chruściel TL; Wilk J; Elertowicz M; Axenti I
    Pol Tyg Lek; 1980 Oct; 35(43):1641-4. PubMed ID: 7255250
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined effects of halothane anesthesia and verapamil on systemic hemodynamics and left ventricular myocardial contractility in patients with ischemic heart disease.
    Schulte-Sasse U; Hess W; Markschies-Hornung A; Tarnow J
    Anesth Analg; 1984 Sep; 63(9):791-8. PubMed ID: 6331775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Verapamil in ischemic pain and arrhythmia].
    Waris E
    Duodecim; 1972; 88(20):1223-32. PubMed ID: 5076303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.